288 related articles for article (PubMed ID: 33858428)
1. Metabolic analysis of early nonalcoholic fatty liver disease in humans using liquid chromatography-mass spectrometry.
Hu C; Wang T; Zhuang X; Sun Q; Wang X; Lin H; Feng M; Zhang J; Cao Q; Jiang Y
J Transl Med; 2021 Apr; 19(1):152. PubMed ID: 33858428
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometry-based untargeted metabolomics study of non-obese individuals with non-alcoholic fatty liver disease.
Demirel M; Köktaşoğlu F; Özkan E; Dulun Ağaç H; Gül AZ; Sharifov R; Sarıkaya U; Başaranoğlu M; Selek Ş
Scand J Gastroenterol; 2023; 58(11):1344-1350. PubMed ID: 37337892
[TBL] [Abstract][Full Text] [Related]
3. Serum metabolome alterations in patients with early nonalcoholic fatty liver disease.
Wang X; Rao B; Wang H; Liu C; Ren Z; Yu Z
Biosci Rep; 2022 Oct; 42(10):. PubMed ID: 36124945
[TBL] [Abstract][Full Text] [Related]
4. A metabolomics approach to the validation of predictive metabolites and phenotypic expression in non-alcoholic fatty liver disease.
Ganesan R; Gupta H; Jeong JJ; Sharma SP; Won SM; Oh KK; Yoon SJ; Kim DJ; Suk KT
Life Sci; 2023 Jun; 322():121626. PubMed ID: 37003543
[TBL] [Abstract][Full Text] [Related]
5. Serum Metabolomics in Patients with Coexisting NAFLD and T2DM Using Liquid Chromatography-Mass Spectrometry.
Hu C; Zhuang X; Zhang J; Wang T; Du S; Wang J; Peng X; Cao Q; Zhang M; Jiang Y
Lab Med; 2022 Jul; 53(4):360-368. PubMed ID: 35075477
[TBL] [Abstract][Full Text] [Related]
6. [Screening of serum oxysterol biomarkers for colon cancer by liquid chromatography-tandem mass spectrometry].
Ma Z; Li Z; Wang H; Wang R; Han X
Se Pu; 2022 Jun; 40(6):541-546. PubMed ID: 35616199
[TBL] [Abstract][Full Text] [Related]
7. Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease.
Dong S; Zhan ZY; Cao HY; Wu C; Bian YQ; Li JY; Cheng GH; Liu P; Sun MY
World J Gastroenterol; 2017 Apr; 23(15):2771-2784. PubMed ID: 28487615
[TBL] [Abstract][Full Text] [Related]
8. Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease.
Barr J; Vázquez-Chantada M; Alonso C; Pérez-Cormenzana M; Mayo R; Galán A; Caballería J; Martín-Duce A; Tran A; Wagner C; Luka Z; Lu SC; Castro A; Le Marchand-Brustel Y; Martínez-Chantar ML; Veyrie N; Clément K; Tordjman J; Gual P; Mato JM
J Proteome Res; 2010 Sep; 9(9):4501-12. PubMed ID: 20684516
[TBL] [Abstract][Full Text] [Related]
9. The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma.
Lewinska M; Santos-Laso A; Arretxe E; Alonso C; Zhuravleva E; Jimenez-Agüero R; Eizaguirre E; Pareja MJ; Romero-Gómez M; Arrese M; Suppli MP; Knop FK; Oversoe SK; Villadsen GE; Decaens T; Carrilho FJ; de Oliveira CP; Sangro B; Macias RIR; Banales JM; Andersen JB
EBioMedicine; 2021 Nov; 73():103661. PubMed ID: 34740106
[TBL] [Abstract][Full Text] [Related]
10. A pilot study optimizing metabolomic and lipidomic acquisition in serum for biomarker discovery in nonalcoholic fatty liver disease.
He D; Su Y; Meng D; Wang X; Wang J; Ye H
J Mass Spectrom Adv Clin Lab; 2021 Nov; 22():17-25. PubMed ID: 34939051
[TBL] [Abstract][Full Text] [Related]
11. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
Lai YS; Chen WC; Kuo TC; Ho CT; Kuo CH; Tseng YJ; Lu KH; Lin SH; Panyod S; Sheen LY
J Agric Food Chem; 2015 Sep; 63(35):7873-84. PubMed ID: 26262841
[TBL] [Abstract][Full Text] [Related]
12. Serum metabolomic analysis of the effect of exercise on nonalcoholic fatty liver disease.
Li J; Zhao Y; Huang C; Chen Z; Shi X; Li L; Chen Z; Li X
Endocr Connect; 2019 Apr; 8(4):299-308. PubMed ID: 30822271
[TBL] [Abstract][Full Text] [Related]
13. Plasma metabolomic profile in nonalcoholic fatty liver disease.
Kalhan SC; Guo L; Edmison J; Dasarathy S; McCullough AJ; Hanson RW; Milburn M
Metabolism; 2011 Mar; 60(3):404-13. PubMed ID: 20423748
[TBL] [Abstract][Full Text] [Related]
14. Metabolomics analysis of the serum metabolic signature of nonalcoholic fatty liver disease combined with prediabetes model rats after the intervention of Lycium barbarum polysaccharides combined with aerobic activity.
Fan Y; Zhang M; Ma J; Zhang Y; Yang J
Biomed Chromatogr; 2023 Apr; 37(4):e5562. PubMed ID: 36480472
[TBL] [Abstract][Full Text] [Related]
15. A targeted metabolomic profiling of plasma acylcarnitines in nonalcoholic fatty liver disease.
Chang Y; Gao XQ; Shen N; He J; Fan X; Chen K; Lin XH; Li HM; Tian FS; Li H
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7433-7441. PubMed ID: 32706083
[TBL] [Abstract][Full Text] [Related]
16. Serum untargeted metabolomics delineates the metabolic status in different subtypes of non-alcoholic fatty liver disease.
Liu L; Zhao J; Zhang R; Wang X; Wang Y; Chen Y; Feng R
J Pharm Biomed Anal; 2021 Jun; 200():114058. PubMed ID: 33865049
[TBL] [Abstract][Full Text] [Related]
17. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
Shang X; Zhong X; Tian X
Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
[TBL] [Abstract][Full Text] [Related]
18. Serum Monounsaturated Triacylglycerol Predicts Steatohepatitis in Patients with Non-alcoholic Fatty Liver Disease and Chronic Hepatitis B.
Yang RX; Hu CX; Sun WL; Pan Q; Shen F; Yang Z; Su Q; Xu GW; Fan JG
Sci Rep; 2017 Sep; 7(1):10517. PubMed ID: 28874844
[TBL] [Abstract][Full Text] [Related]
19. Serum metabonomics of NAFLD plus T2DM based on liquid chromatography-mass spectrometry.
Chen Y; Li C; Liu L; Guo F; Li S; Huang L; Sun C; Feng R
Clin Biochem; 2016 Sep; 49(13-14):962-6. PubMed ID: 27211699
[TBL] [Abstract][Full Text] [Related]
20. Sex-Specific Metabolite Biomarkers of NAFLD in Youth: A Prospective Study in the EPOCH Cohort.
Perng W; Francis EC; Smith HA; Carey J; Wang D; Kechris KM; Dabelea D
J Clin Endocrinol Metab; 2020 Sep; 105(9):e3437-50. PubMed ID: 32687159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
